Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huoxue Baoxin Pills versus syndrome-differentiated TCM treatment in coronary heart disease with TCM syndromes
ChiCTR-TRC-12002924Phase 4Completed
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Huoxue Baoxin Pill in coronary arteriosclerosis and angina pectoris (2 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Disease index and Syndrome indicator. Started Jan 2010; status: completed.
02
Drugs
Huoxue Baoxin Pill
03
Conditions
coronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on ChiCTR-TRC-12002924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002924.